Avalon Advanced Materials
TSE:AVLAvalon Advanced Materials Inc., together with its subsidiaries, engages in the acquisition, exploration, evaluation, and development of rare metal and mineral properties primarily in Canada. The company focuses on exploring lithium, tantalum, cesium, indium, gallium, germanium, tin, yttrium, and zirconium deposits, as well as rare earth elements. Its flagship project is the 100% owned Separation Rapids Lithium Project consisting of nineteen mineral claims and one mining lease covering an area of approximately 4,414 hectares located in the Paterson Lake Area, Kenora Mining Division, Ontario. The company was formerly known as Avalon Rare Metals Inc. and changed its name to Avalon Advanced Materials Inc. in February 2016. Avalon Advanced Materials Inc. is headquartered in Toronto, Canada.
Emerald Health Therapeutics
CVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
Plateau Energy Metals
CVE:PLUPlateau Energy Metals Inc., a junior resource company, engages in the acquisition, exploration, and evaluation of mineral properties in Peru. The company explores for lithium and uranium deposits. It holds interests in Falchani Lithium Project and Macusani Uranium Project in the Puno District of southeastern Peru. The company also holds a total of 151 mining concessions covering approximately 93,000 hectares on the Macusani Plateau in Peru. The company was formerly known as Plateau Uranium Inc. and changed its name to Plateau Energy Metals Inc. in March 2018. The company was founded in 2006 and is headquartered in Toronto, Canada.
Columbia Growth Equity Strategy Fund
NYSEARCA:RPXColumbia Large Cap Growth ETF, formerly Columbia Growth Equity Strategy Fund, seeks long-term capital appreciation by investing at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of companies. The Fund may invest in companies of any market capitalization and in any industry. It expects to invest primarily in the securities of United States companies, and may also invest in United States securities tied economically to foreign investments, such as American Depositary Receipts. It invests in various sectors, such as information technology, industrials, healthcare, energy, financials, consumer staples, financials, materials and consumer discretionary. Columbia Management Investment Advisers, LLC serves as the manager of the Fund.
